Clinical Trials Browser

Phase NA × INDUSTRY × pembrolizumab × Clear all

NCT05047094 2026-04-06

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Phase NA Recruiting

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT04453046 2022-12-20

Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

Phase NA Terminated

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms